Screening of nasopharyngeal cancer in high-risk familial cohort: A practical approach using a screening algorithm

Author:

Wee Jia Jia1,Jang Isabelle Jia Hui1,Teo Neville Wei Yang1,Loh Ian Chi Yuan2,Charn Tze Choong3,Eu Donovan Kum Chuen4,Tsang Raymond King Yin4,Lim Ming Yann5,Huang Lilleen Minyi6,Mok Paul Kan Hwei7,Toh Song Tar1,Lim Chwee Ming1

Affiliation:

1. Singapore General Hospital, Singapore

2. Changi General Hospital, Singapore

3. Sengkang General Hospital, Singapore

4. National University Hospital, Singapore

5. Tan Tock Seng Hospital, Singapore

6. Khoo Teck Puat Hospital, Singapore

7. Mount Elizabeth Novena Specialist Centre and Farrer Park Hospital, Singapore

Abstract

In Singapore, nasopharyngeal cancer (NPC) is among the top 3 cancers afflicting middle-aged males (30–49 years old).1 Unfortunately, patients with early-stage NPC are often asymptomatic, and most patients (approx. 70%) are diagnosed with advanced disease with adversely reduced survival. First-degree relatives of NPC patients have about 4 to 10 times increased risk of developing NPC,2 and strategies for reducing NPC-specific mortality among this high-risk group are feasible. Herein, a working group from the Chapter Board of Otorhinolaryngologists Singapore proposed a screening algorithm for these high-risk individuals of NPC based on existing available evidence.

Publisher

Academy of Medicine, Singapore

Reference12 articles.

1. Ministry of Health Singapore, National Registry of Disease Office. Singapore Cancer Registry Annual Report 2021. https://nrdo.gov.sg/publications/cancer. Accessed 23 Dec 2023.

2. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-77.

3. Ministry of Health, Singapore. Cancer Screening—MOH Clinical Practice Guidelines 1/2010, February 2010. https://www. moh.gov.sg/docs/librariesprovider4/guidelines/cpg_cancer screening.pdf. Accessed 18 Nov 2023.

4. Ng WT, Yau TK, Yung RWH, et al. Screening for family members of patients with nasopharyngeal carcinoma. Int J Cancer 2005;113:998-1001.

5. Tay JK, Siow CH, Goh HL, et al. A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: results of the Singapore NPC screening cohort. Int J Cancer 2020;146:2923-31.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3